How to develop robust solid oral dosage forms: from conception to post-approval
How to Develop Robust Solid Oral Dosage Forms from Conception to Post-Approval uses a practical and hands-on approach to cover the development process of solid oral dosage forms in one single source. The book details all of the necessary steps from formulation through the post-approval phase and con...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Amsterdam ; Boston ; Heidelberg ; London ; New York
Academic Press is an imprint of Elsevier
[2017]
|
Schriftenreihe: | Expertise in pharmaceutical process technology series
|
Schlagworte: | |
Zusammenfassung: | How to Develop Robust Solid Oral Dosage Forms from Conception to Post-Approval uses a practical and hands-on approach to cover the development process of solid oral dosage forms in one single source. The book details all of the necessary steps from formulation through the post-approval phase and contains industry case studies, real world advice, and troubleshooting tips. By merging the latest scientific information with practical instructions, this book provides pharmaceutical scientists in formulation research and development with a concrete look at the key aspects in the development of solid oral dosage forms.... |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | xxii, 168 Seiten Illustrationen, Diagramme 23 cm |
ISBN: | 9780128047316 0128047313 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV044559319 | ||
003 | DE-604 | ||
005 | 20171127 | ||
007 | t | ||
008 | 171027s2017 ne a||| |||| 00||| eng d | ||
010 | |a 016942143 | ||
020 | |a 9780128047316 |9 978-0-12-804731-6 | ||
020 | |a 0128047313 |9 0-12-804731-3 | ||
035 | |a (OCoLC)1013180450 | ||
035 | |a (DE-599)BVBBV044559319 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a ne |c NL | ||
049 | |a DE-19 | ||
050 | 0 | |a RS201.S57 | |
082 | 0 | |a 615.1 |2 23 | |
084 | |a VX 6000 |0 (DE-625)147803:253 |2 rvk | ||
100 | 1 | |a Mittal, Bhavishya |4 aut | |
245 | 1 | 0 | |a How to develop robust solid oral dosage forms |b from conception to post-approval |c Bhavishya Mittal ; series editor, Michael Levin, Milev, LLC, Pharmaceutical Technology Consulting, West Orange, NJ, United States |
264 | 1 | |a Amsterdam ; Boston ; Heidelberg ; London ; New York |b Academic Press is an imprint of Elsevier |c [2017] | |
300 | |a xxii, 168 Seiten |b Illustrationen, Diagramme |c 23 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Expertise in pharmaceutical process technology series | |
500 | |a Includes bibliographical references and index | ||
520 | |a How to Develop Robust Solid Oral Dosage Forms from Conception to Post-Approval uses a practical and hands-on approach to cover the development process of solid oral dosage forms in one single source. The book details all of the necessary steps from formulation through the post-approval phase and contains industry case studies, real world advice, and troubleshooting tips. By merging the latest scientific information with practical instructions, this book provides pharmaceutical scientists in formulation research and development with a concrete look at the key aspects in the development of solid oral dosage forms.... | ||
650 | 4 | |a Drugs / Dosage forms / fast / (OCoLC)fst00898801 | |
650 | 4 | |a Pharmacology / fast / (OCoLC)fst01060259 | |
650 | 4 | |a Pharmacology | |
650 | 4 | |a Drugs |x Dosage forms | |
650 | 4 | |a Dosage Forms | |
650 | 4 | |a Administration, Oral | |
650 | 4 | |a Technology, Pharmaceutical | |
650 | 4 | |a Drugs | |
650 | 4 | |a Pharmacology | |
999 | |a oai:aleph.bib-bvb.de:BVB01-029957971 |
Datensatz im Suchindex
_version_ | 1804177929122349056 |
---|---|
any_adam_object | |
author | Mittal, Bhavishya |
author_facet | Mittal, Bhavishya |
author_role | aut |
author_sort | Mittal, Bhavishya |
author_variant | b m bm |
building | Verbundindex |
bvnumber | BV044559319 |
callnumber-first | R - Medicine |
callnumber-label | RS201 |
callnumber-raw | RS201.S57 |
callnumber-search | RS201.S57 |
callnumber-sort | RS 3201 S57 |
callnumber-subject | RS - Pharmacy |
classification_rvk | VX 6000 |
ctrlnum | (OCoLC)1013180450 (DE-599)BVBBV044559319 |
dewey-full | 615.1 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.1 |
dewey-search | 615.1 |
dewey-sort | 3615.1 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02267nam a2200469 c 4500</leader><controlfield tag="001">BV044559319</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20171127 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">171027s2017 ne a||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">016942143</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128047316</subfield><subfield code="9">978-0-12-804731-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0128047313</subfield><subfield code="9">0-12-804731-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1013180450</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044559319</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">ne</subfield><subfield code="c">NL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS201.S57</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 6000</subfield><subfield code="0">(DE-625)147803:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mittal, Bhavishya</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">How to develop robust solid oral dosage forms</subfield><subfield code="b">from conception to post-approval</subfield><subfield code="c">Bhavishya Mittal ; series editor, Michael Levin, Milev, LLC, Pharmaceutical Technology Consulting, West Orange, NJ, United States</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam ; Boston ; Heidelberg ; London ; New York</subfield><subfield code="b">Academic Press is an imprint of Elsevier</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxii, 168 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">23 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Expertise in pharmaceutical process technology series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">How to Develop Robust Solid Oral Dosage Forms from Conception to Post-Approval uses a practical and hands-on approach to cover the development process of solid oral dosage forms in one single source. The book details all of the necessary steps from formulation through the post-approval phase and contains industry case studies, real world advice, and troubleshooting tips. By merging the latest scientific information with practical instructions, this book provides pharmaceutical scientists in formulation research and development with a concrete look at the key aspects in the development of solid oral dosage forms....</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Dosage forms / fast / (OCoLC)fst00898801</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology / fast / (OCoLC)fst01060259</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Dosage forms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dosage Forms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Administration, Oral</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029957971</subfield></datafield></record></collection> |
id | DE-604.BV044559319 |
illustrated | Illustrated |
indexdate | 2024-07-10T07:55:53Z |
institution | BVB |
isbn | 9780128047316 0128047313 |
language | English |
lccn | 016942143 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029957971 |
oclc_num | 1013180450 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | xxii, 168 Seiten Illustrationen, Diagramme 23 cm |
publishDate | 2017 |
publishDateSearch | 2017 |
publishDateSort | 2017 |
publisher | Academic Press is an imprint of Elsevier |
record_format | marc |
series2 | Expertise in pharmaceutical process technology series |
spelling | Mittal, Bhavishya aut How to develop robust solid oral dosage forms from conception to post-approval Bhavishya Mittal ; series editor, Michael Levin, Milev, LLC, Pharmaceutical Technology Consulting, West Orange, NJ, United States Amsterdam ; Boston ; Heidelberg ; London ; New York Academic Press is an imprint of Elsevier [2017] xxii, 168 Seiten Illustrationen, Diagramme 23 cm txt rdacontent n rdamedia nc rdacarrier Expertise in pharmaceutical process technology series Includes bibliographical references and index How to Develop Robust Solid Oral Dosage Forms from Conception to Post-Approval uses a practical and hands-on approach to cover the development process of solid oral dosage forms in one single source. The book details all of the necessary steps from formulation through the post-approval phase and contains industry case studies, real world advice, and troubleshooting tips. By merging the latest scientific information with practical instructions, this book provides pharmaceutical scientists in formulation research and development with a concrete look at the key aspects in the development of solid oral dosage forms.... Drugs / Dosage forms / fast / (OCoLC)fst00898801 Pharmacology / fast / (OCoLC)fst01060259 Pharmacology Drugs Dosage forms Dosage Forms Administration, Oral Technology, Pharmaceutical Drugs |
spellingShingle | Mittal, Bhavishya How to develop robust solid oral dosage forms from conception to post-approval Drugs / Dosage forms / fast / (OCoLC)fst00898801 Pharmacology / fast / (OCoLC)fst01060259 Pharmacology Drugs Dosage forms Dosage Forms Administration, Oral Technology, Pharmaceutical Drugs |
title | How to develop robust solid oral dosage forms from conception to post-approval |
title_auth | How to develop robust solid oral dosage forms from conception to post-approval |
title_exact_search | How to develop robust solid oral dosage forms from conception to post-approval |
title_full | How to develop robust solid oral dosage forms from conception to post-approval Bhavishya Mittal ; series editor, Michael Levin, Milev, LLC, Pharmaceutical Technology Consulting, West Orange, NJ, United States |
title_fullStr | How to develop robust solid oral dosage forms from conception to post-approval Bhavishya Mittal ; series editor, Michael Levin, Milev, LLC, Pharmaceutical Technology Consulting, West Orange, NJ, United States |
title_full_unstemmed | How to develop robust solid oral dosage forms from conception to post-approval Bhavishya Mittal ; series editor, Michael Levin, Milev, LLC, Pharmaceutical Technology Consulting, West Orange, NJ, United States |
title_short | How to develop robust solid oral dosage forms |
title_sort | how to develop robust solid oral dosage forms from conception to post approval |
title_sub | from conception to post-approval |
topic | Drugs / Dosage forms / fast / (OCoLC)fst00898801 Pharmacology / fast / (OCoLC)fst01060259 Pharmacology Drugs Dosage forms Dosage Forms Administration, Oral Technology, Pharmaceutical Drugs |
topic_facet | Drugs / Dosage forms / fast / (OCoLC)fst00898801 Pharmacology / fast / (OCoLC)fst01060259 Pharmacology Drugs Dosage forms Dosage Forms Administration, Oral Technology, Pharmaceutical Drugs |
work_keys_str_mv | AT mittalbhavishya howtodeveloprobustsolidoraldosageformsfromconceptiontopostapproval |